Founder and President, Oxford Biomedical Research in Oxford, Michigan. Callewaert, a professor of chemistry and the former director of the Center for Biomedical Research at Oakland University, founded the company in 1994, one of four biotechnology companies he has started. Oxford Biomedical Research has licensed several key technologies and performs research and development through grants and contracts from the National Institutes of Health. Callewaertís work has appeared in more than 70 research publications, and he holds several patents. Prior to Oxford, Callewaert was the co-founder of the Michigan Biotechnology Association (now MichBio), a consultant in the clinical pathology department at William Beaumont Hospital in Royal Oak, and president of Proteins International in Rochester Hills. Callewaert and Oxford Biomedical have been recognized with the Commercialization Assistance Program award from the National Institutes of Health, the Commercialization Success award from the MEDC, and the Research Career Development award from the National Cancer Institute. He was named a special fellow of the Leukemia Society of America. He received his bachelorís degree in chemistry from what is now the University of Detroit Mercy and his PhD in chemistry/biochemistry from Wayne State University.